Exchange: OTC·Updated 12:19 PM EDT

EMMLD OKYO Pharma Limited

$1.52
$0.02
(1.33%)
Today
Mkt Cap$78.72M
Vol10,892.00

About EMMLD

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
50

Neutral Sentiment

How do you feel about EMMLD?

Advertisement|Remove ads.